Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Inactive Actions
Menu Item - Inactive Actions
Menu Item - Agenda Search
Menu Item - Agenda XML Reports
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR
       Search

Pending EO 12866 Regulatory Review


RIN: 0906-AB12         View EO 12866 Meetings Received Date: 10/06/2017 
Title: 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation 
Agency/Subagency: HHS / HRSA   Stage: Proposed Rule 
Legal Deadline: None  Economically Significant: No 
International Impacts: No Affordable Care Act [PPACA, P.L. 111-148 & 111-152]: No
  Dodd-Frank Act [Dodd-Frank Wall Street Reform and Consumer Protection Act, P.L. 111-203]: No

About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us  
 
Apple Store Badge                 Get it on Google Play